Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The use of vaccine platform technologies greatly reduces the time and money required to develop a novel vaccine against an infectious disease, but much work is still needed if vaccines are to protect the world from the next pandemic.

Original publication

DOI

10.1371/journal.pbio.3003114

Type

Journal article

Journal

PLoS Biol

Publication Date

04/2025

Volume

23

Keywords

Humans, Cost-Benefit Analysis, Disease Outbreaks, Vaccines, Pandemics, COVID-19, Vaccine Development, COVID-19 Vaccines, SARS-CoV-2